Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 2
1990 2
1992 1
1993 1
1994 4
1995 3
1996 3
1997 3
1998 6
1999 9
2000 4
2001 6
2002 9
2003 10
2004 7
2005 5
2006 5
2007 12
2008 14
2009 11
2010 7
2011 7
2012 9
2013 8
2014 7
2015 13
2016 11
2017 12
2018 9
2019 13
2020 8
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

204 results
Results by year
Filters applied: . Clear all
Page 1
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Aparicio AM, et al. Among authors: thall pf. Clin Cancer Res. 2013 Jul 1;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12-3791. Epub 2013 May 6. Clin Cancer Res. 2013. PMID: 23649003 Free PMC article.
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML. Maki RG, et al. Among authors: thall pf. J Clin Oncol. 2007 Jul 1;25(19):2755-63. doi: 10.1200/JCO.2006.10.4117. J Clin Oncol. 2007. PMID: 17602081 Clinical Trial.
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.
Bashir Q, Thall PF, Milton DR, Fox PS, Kawedia JD, Kebriaei P, Shah N, Patel K, Andersson BS, Nieto YL, Valdez BC, Parmar S, Rondon G, Delgado R, Hosing C, Popat UR, Oran B, Ciurea SO, Lin P, Weber DM, Thomas SK, Lee HC, Manasanch EE, Orlowski RZ, Williams LA, Champlin RE, Qazilbash MH. Bashir Q, et al. Among authors: thall pf. Lancet Haematol. 2019 May;6(5):e266-e275. doi: 10.1016/S2352-3026(19)30023-7. Epub 2019 Mar 22. Lancet Haematol. 2019. PMID: 30910541 Clinical Trial.
A review of phase 2-3 clinical trial designs.
Thall PF. Thall PF. Lifetime Data Anal. 2008 Mar;14(1):37-53. doi: 10.1007/s10985-007-9049-x. Epub 2007 Sep 2. Lifetime Data Anal. 2008. PMID: 17763973 Review.
In Reply to Krishnatry and Manjali.
Amsbaugh MJ, Mahajan A, Thall PF, McAleer MF, Paulino AC, Grosshans D, Khatua S, Ketonen L, Fontanilla H, McGovern SL. Amsbaugh MJ, et al. Among authors: thall pf. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):468-469. doi: 10.1016/j.ijrobp.2019.02.037. Int J Radiat Oncol Biol Phys. 2019. PMID: 31047634 No abstract available.
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K. Ciurea SO, et al. Among authors: thall pf. Biol Blood Marrow Transplant. 2015 Aug;21(8):1392-8. doi: 10.1016/j.bbmt.2015.05.001. Epub 2015 May 15. Biol Blood Marrow Transplant. 2015. PMID: 25985919 Free PMC article.
204 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page